SATIETY INC

PALO ALTO, CA · Biotech · Still private

GLP-1 receptor agonist formulations (triGLP and IGNYT) for metabolic and nutritional optimization

Claim this profile

Follows are private to you and power your alerts

Updated · satiety.com

Sector
Biotech
Headquarters
PALO ALTO, CA
Latest Form D
$25.3M, Sep 2009
Total capital
$34.3M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$34.3M
2 Form D · last Sep 2009
205 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
15 pending

Capital timeline

2009FEDERAL ↑EQUITY ↓Cumulative $34.3M1st Form D$9M2nd Form D$25.3M
2009FEDERAL ↑EQUITY ↓Cumulative $34.3M1st Form D$9M2nd Form D$25.3M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$25.3M
  • Private capital raisedForm D · SEC · 1st filing$9M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Bryan E. Roberts, Ph.D.DirectorNamed in SEC Form D filings
  • Eric ReuterExecutive Officer, DirectorNamed in SEC Form D filings
  • Henry Plain, Jr.DirectorNamed in SEC Form D filings
  • John FreundDirectorNamed in SEC Form D filings
  • Michael BatesDirectorNamed in SEC Form D filings
  • Rod YoungDirectorNamed in SEC Form D filings
Show all 7 people
  • Thomas Fogarty, M.D.DirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 15
  • PendingDevices And Methods For Placement Of Partitions Within A Hollow Body OrganUSPTOApplication PCTUS2007086599
  • PendingDevices And Methods For Placement Of Partitions Within A Hollow Body OrganUSPTOApplication PCTUS2006048779
  • PendingRemote Tissue Retraction DeviceUSPTOApplication PCTUS2005041881
Show all 15 patent records
  • Devices And Methods For Placement Of Partitions Within A Hollow Body OrganApplication PCTUS2007086599Pending
  • Devices And Methods For Placement Of Partitions Within A Hollow Body OrganApplication PCTUS2006048779Pending
  • Remote Tissue Retraction DeviceApplication PCTUS2005041881Pending
  • Single Fold Device For Tissue FixationApplication PCTUS2005013740Pending
  • Systems And Methods For Treating ObesityApplication PCTUS2005010050Pending
  • Methods And Devices For Reducing Hollow Organ VolumeApplication PCTUS2005006144Pending
  • Devices And Methods For Placement Of Partitions Within A Hollow Body OrganApplication PCTUS2005004697Pending
  • Methods For Reducing Hollow Organ VolumeApplication PCTUS2005004692Pending
  • Method And Devices For Modifying The Function Of A Body OrganApplication PCTUS2004011791Pending
  • Method And Device For Use In Endoscopic Orga ProceduresApplication PCTUS2003031546Pending
  • Method And Devices For Maintaining A Space Occupying Device In A Relatively Fixed Location Within A StomachApplication PCTUS2003027296Pending
  • Method And Device For Use In Tissue Approximation And FixationApplication PCTUS2003019617Pending
  • Intra-gastric Fastening DevicesApplication PCTUS2003008853Pending
  • Obesity Treatment Tools And MethodsApplication PCTUS2002017077Pending
  • Method And Device For Use In Minimally Inv Asive Placement Of Intragastric DevicesApplication PCTUS2001043868Pending

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .